| Fiscal Year End | Company Status | Exempt Flag |
| June 30 | Trading | N |
|
|
|
|
|
| Incorporation Locations |
| Inc. Date | Expiry Date | Country | Region | Description |
| 21/Apr/2018 | | Canada | British Columbia | |
|
|
| Exchange Filing Office |
| Location |
| Vancouver Regional Service Office |
|
|  |
| Business Type(s) |
| Primary/Secondary | Business Type | Details |
| Primary
| Research And Development In The Life Sciences
| (not available)
|
|
|
| Securities |
| Symbol | Security Name | Market | Status |
| NAV | NAVCO Pharmaceuticals Inc. | TSX Venture | TRADING |
|
|
| Name History | From | To |
| NAVCO Pharmaceuticals Inc. | 18/Apr/2023 | Present |
|
|
| Company Facts Reconciliation |
| Subject | Date Returned |
| (not available) |
|
|
|
|
|
